Literature DB >> 3547624

Chromosomal beta-lactam resistance in enterobacteria.

S Normark, S Lindquist, F Lindberg.   

Abstract

Most enterobacterial species carry a chromosomal ampC beta-lactamase gene. In Escherichia coli and Shigella, expression from ampC is non-inducible and the beta-lactamase is synthesized at low levels. Mutations leading to increased beta-lactamase synthesis occur rather infrequently, making resistance to modern cephalosporins a rare event in these species. In other enterobacteria and Pseudomonas, ampC beta-lactamase synthesis is induced by beta-lactams. In Enterobacter cloacae, Citrobacter freundii and probably also in other species with inducible beta-lactamase expression, ampC is regulated by at least two genes, ampR and ampD. Mutations affecting ampR abolish beta-lactamase inducibility, and mutants devoid of ampR, produce ampC beta-lactamase at low constitutive levels. Mutations in ampD lead to constitutive overproduction of inducible beta-lactamase if an intact ampR protein is present in the cell. The latter type of mutations occur at a high frequency and result in clinical resistance to several third-generation cephalosporins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3547624

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  12 in total

Review 1.  Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.

Authors:  Deepak Balasubramanian; Hansi Kumari; Kalai Mathee
Journal:  Pathog Dis       Date:  2015-02-26       Impact factor: 3.166

Review 2.  Cell-Wall Recycling of the Gram-Negative Bacteria and the Nexus to Antibiotic Resistance.

Authors:  David A Dik; Jed F Fisher; Shahriar Mobashery
Journal:  Chem Rev       Date:  2018-05-30       Impact factor: 60.622

3.  Structural and functional characterization of Pseudomonas aeruginosa global regulator AmpR.

Authors:  Olivier Caille; Diansy Zincke; Massimo Merighi; Deepak Balasubramanian; Hansi Kumari; Kok-Fai Kong; Eugenia Silva-Herzog; Giri Narasimhan; Lisa Schneper; Stephen Lory; Kalai Mathee
Journal:  J Bacteriol       Date:  2014-09-02       Impact factor: 3.490

4.  Promoter sequences necessary for high-level expression of the plasmid-associated ampC beta-lactamase gene blaMIR-1.

Authors:  Mark D Reisbig; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

5.  Role of Pseudomonas aeruginosa AmpR on β-lactam and non-β-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics.

Authors:  Hansi Kumari; Deepak Balasubramanian; Diansy Zincke; Kalai Mathee
Journal:  J Med Microbiol       Date:  2014-01-25       Impact factor: 2.472

6.  New method for laboratory detection of AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae.

Authors:  K Nasim; S Elsayed; J D D Pitout; J Conly; D L Church; D B Gregson
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

7.  Automated Broad-Range Molecular Detection of Bacteria in Clinical Samples.

Authors:  Andries E Budding; Martine Hoogewerf; Christina M J E Vandenbroucke-Grauls; Paul H M Savelkoul
Journal:  J Clin Microbiol       Date:  2016-01-13       Impact factor: 5.948

8.  Molecular mechanism of P pilus termination in uropathogenic Escherichia coli.

Authors:  Denis Verger; Eric Miller; Han Remaut; Gabriel Waksman; Scott Hultgren
Journal:  EMBO Rep       Date:  2006-11-03       Impact factor: 8.807

9.  The regulatory repertoire of Pseudomonas aeruginosa AmpC ß-lactamase regulator AmpR includes virulence genes.

Authors:  Deepak Balasubramanian; Lisa Schneper; Massimo Merighi; Roger Smith; Giri Narasimhan; Stephen Lory; Kalai Mathee
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

10.  Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes.

Authors:  A Oliver; M Pérez-Vázquez; M Martínez-Ferrer; F Baquero; L De Rafael; R Cantón
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.